PT Mark Dynamics Indonesia Tbk (MARK.JK)
IDR 1060.0
(-2.3%)
IDR 1060.0
(-2.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 234.35 Billion IDR | -34.85% |
| 2022 | 344.16 Billion IDR | -36.2% |
| 2021 | 533.6 Billion IDR | 164.7% |
| 2020 | 211.15 Billion IDR | 57.09% |
| 2019 | 132.71 Billion IDR | 8.84% |
| 2018 | 122.97 Billion IDR | 66.67% |
| 2017 | 68.51 Billion IDR | 109.93% |
| 2016 | 36.68 Billion IDR | 97.6% |
| 2015 | 16.47 Billion IDR | 52.51% |
| 2014 | 10.84 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 97.57 Billion IDR | -12.4% |
| 2024 Q2 | 108.83 Billion IDR | 9.55% |
| 2024 Q1 | 95.33 Billion IDR | 29.69% |
| 2023 Q3 | 49.35 Billion IDR | 2.78% |
| 2023 FY | - IDR | -34.85% |
| 2023 Q1 | 43.97 Billion IDR | 10.05% |
| 2023 Q2 | 48.02 Billion IDR | 9.21% |
| 2023 Q4 | 73.45 Billion IDR | 48.83% |
| 2022 Q2 | 99.63 Billion IDR | -42.99% |
| 2022 Q3 | 15.35 Billion IDR | -84.59% |
| 2022 Q4 | 39.95 Billion IDR | 160.26% |
| 2022 FY | - IDR | -36.2% |
| 2022 Q1 | 174.77 Billion IDR | 16.75% |
| 2021 Q3 | 162.39 Billion IDR | 42.33% |
| 2021 FY | - IDR | 164.7% |
| 2021 Q4 | 149.69 Billion IDR | -7.82% |
| 2021 Q1 | 92.14 Billion IDR | 15.02% |
| 2021 Q2 | 114.1 Billion IDR | 23.82% |
| 2020 Q1 | 32.21 Billion IDR | 1.8% |
| 2020 Q2 | 35.23 Billion IDR | 9.38% |
| 2020 FY | - IDR | 57.09% |
| 2020 Q4 | 80.11 Billion IDR | 68.07% |
| 2020 Q3 | 47.66 Billion IDR | 35.27% |
| 2019 Q4 | 31.64 Billion IDR | 8.07% |
| 2019 FY | - IDR | 8.84% |
| 2019 Q3 | 29.28 Billion IDR | -7.05% |
| 2019 Q2 | 31.5 Billion IDR | -1.07% |
| 2019 Q1 | 31.84 Billion IDR | -3.29% |
| 2018 Q3 | 28.75 Billion IDR | 10.44% |
| 2018 FY | - IDR | 66.67% |
| 2018 Q4 | 32.92 Billion IDR | 14.5% |
| 2018 Q1 | 25.66 Billion IDR | 23.81% |
| 2018 Q2 | 26.03 Billion IDR | 1.44% |
| 2017 FY | - IDR | 109.93% |
| 2017 Q1 | 9.03 Billion IDR | -42.81% |
| 2017 Q2 | 15.11 Billion IDR | 67.25% |
| 2017 Q3 | 23.63 Billion IDR | 56.37% |
| 2017 Q4 | 20.73 Billion IDR | -12.27% |
| 2016 Q3 | 10.33 Billion IDR | 109.26% |
| 2016 FY | - IDR | 97.6% |
| 2016 Q2 | 4.94 Billion IDR | -0.0% |
| 2016 Q1 | 4.94 Billion IDR | 0.0% |
| 2016 Q4 | 15.79 Billion IDR | 52.79% |
| 2015 FY | - IDR | 52.51% |
| 2014 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Hetzer Medical Indonesia Tbk | 1.22 Billion IDR | -18986.932% |
| PT Jayamas Medica Industri Tbk | 371.38 Billion IDR | 36.896% |
| Maja Agung Latexindo Tbk. | 978.07 Million IDR | -23861.083% |